Safety and efficacy of chronic suppressive azole therapy for endemic fungal infections in solid organ transplant recipients

Sonya A. Trinh*, Ignacio A. Echenique, Sudhir Penugonda, Michael P. Angarone

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Background: Although the research is limited, treatment guidelines recommend lifelong suppressive azole therapy for disseminated endemic fungal infection (EFI) after solid organ transplantation (SOT). Suppressive azole therapy may prevent EFI recurrence at the risk of hepatotoxicity and drug interactions. We present real-world safety and effectiveness data of chronic suppressive azole therapy for EFI in SOT recipients over a 10-year period at a single comprehensive transplant center. Methods: A retrospective analysis was conducted of SOT recipients diagnosed with EFI from January 1, 2005, to May 1, 2015. Chronic suppressive azole therapy was defined as treatment for more than 12 months after diagnosis. Effectiveness of suppression was defined as preventing EFI reactivation. Safety endpoints included adverse reactions and drug interactions. Results: Over a 10-year period, 28 SOT recipients were diagnosed with EFI: 16 histoplasmosis, 9 blastomycosis, and 3 coccidioidomycosis. Eighteen (64%) patients were treated with chronic suppressive azole therapy for a median length of 36 months (range 15-90). One patient had an adverse drug interaction requiring azole discontinuation. There were no episodes of azole-related hepatotoxicity, toxicity from antirejection medication, or EFI reactivation. Conclusions: Chronic suppressive azole therapy was safe and effective in preventing reactivation of EFI in SOT recipients.

Original languageEnglish (US)
Article numbere12963
JournalTransplant Infectious Disease
Volume20
Issue number5
DOIs
StatePublished - Oct 2018

Keywords

  • blastomycosis
  • coccidioidomycosis
  • endemic fungal infection
  • histoplasmosis
  • solid organ transplant

ASJC Scopus subject areas

  • Infectious Diseases
  • Transplantation

Fingerprint Dive into the research topics of 'Safety and efficacy of chronic suppressive azole therapy for endemic fungal infections in solid organ transplant recipients'. Together they form a unique fingerprint.

  • Cite this